Ryosuke Munakata
Investment Director
Radiology
Astella LLC
Mongolia
Biography
Dr. Munakata joined AVM in April 2016. He is a medicinal chemist by training and has more than 10 years of experiences of drug discovery research in the field of pain, CNS, muscle-related disorders, and nephrology at Astellas Pharma Inc. and covers broad stage of drug discovery from pre-hit identification to preclinical development with successful experience, including multiple research collaborations with external partners. His expertise as a scientist includes medicinal chemistry, synthetic organic chemistry, structure-based drug discovery, and cheminformatics. Prior to joining AVM, he served as an Associate Director at Innovation Management, Astellas Pharma Inc., in charge of business transaction for partnering deals as well as alliance management for ongoing collaboration. Since his transfer to investment side, he has led multiple investment opportunities at AVM to successfully close the deals.
Research Interest
Dr. Munakata joined AVM in April 2016. He is a medicinal chemist by training and has more than 10 years of experiences of drug discovery research in the field of pain, CNS, muscle-related disorders, and nephrology at Astellas Pharma Inc. and covers broad stage of drug discovery from pre-hit identification to preclinical development with successful experience, including multiple research collaborations with external partners. His expertise as a scientist includes medicinal chemistry, synthetic organic chemistry, structure-based drug discovery, and cheminformatics. Prior to joining AVM, he served as an Associate Director at Innovation Management, Astellas Pharma Inc., in charge of business transaction for partnering deals as well as alliance management for ongoing collaboration. Since his transfer to investment side, he has led multiple investment opportunities at AVM to successfully close the deals.
